1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berndt, MC; Bobik, A; Jennings, G; Kannelakis, P; Taylor, AJ | 1 |
| Fan, J; Iwasa, S; Miyauchi, T; Watanabe, T | 1 |
2 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Arteriosclerosis
| Article | Year |
|---|---|
Serotonin blockade protects against early microvascular constriction following atherosclerotic plaque rupture.
Topics: Animals; Arteriosclerosis; Blood Flow Velocity; Disease Models, Animal; Iliac Artery; Indans; Microcirculation; Rabbits; Receptors, Serotonin, 5-HT2; Ritanserin; Rupture; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction | 2004 |
Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Blood Pressure; Cholesterol, Dietary; Cholesterol, VLDL; Diet; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hypercholesterolemia; Indans; Lipoproteins; Male; Mice; Triglycerides | 2001 |